Jaume Mora

Summary

Country: Spain

Publications

  1. ncbi request reprint Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations
    Jaume Mora
    Laboratori de biologia molecular dels tumors del desenvolupament i Oncologia Pediàtrica, Hospital Sant Joan de Deu de Barcelona, Spain
    Pediatr Blood Cancer 47:785-9. 2006
  2. ncbi request reprint Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma
    Jaume Mora
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain
    Genes Chromosomes Cancer 46:385-96. 2007
  3. doi request reprint Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 58:532-8. 2012
  4. doi request reprint Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 57:69-75. 2011
  5. pmc Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours
    J Mora
    Department of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Br J Cancer 91:1112-8. 2004
  6. doi request reprint Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel
    Jaume Mora
    Department of Pediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    J Pediatr Hematol Oncol 31:723-9. 2009
  7. ncbi request reprint Origin of neuroblastic tumors: clues for future therapeutics
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Passeig de Sant Joan de Deu num 2, 08950 Barcelona, Spain
    Expert Rev Mol Diagn 4:293-302. 2004
  8. doi request reprint Treatment of disseminated paraganglioma with gemcitabine and docetaxel
    Jaume Mora
    Department of Pediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 53:663-5. 2009
  9. pmc Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin
    Jaume Mora
    Department of Pediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Passeig de Sant Joan de Déu numero 2, 08950 Barcelona, Spain
    Neuro Oncol 9:39-46. 2007
  10. ncbi request reprint Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center
    Jaume Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 98:1283-91. 2003

Collaborators

Detail Information

Publications50

  1. ncbi request reprint Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations
    Jaume Mora
    Laboratori de biologia molecular dels tumors del desenvolupament i Oncologia Pediàtrica, Hospital Sant Joan de Deu de Barcelona, Spain
    Pediatr Blood Cancer 47:785-9. 2006
    ..The aim of this study was to determine the rate of germline mutations among the rare patients presenting with sporadic PGL during childhood...
  2. ncbi request reprint Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma
    Jaume Mora
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain
    Genes Chromosomes Cancer 46:385-96. 2007
    ..02; progression-free survival, P = 0.01). These results provide strong evidence for clonal ploidy heterogeneity in LR NB and clonal evolution toward diploidy in progressing LR NB...
  3. doi request reprint Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 58:532-8. 2012
    ..The objective of the current study was to determine the relation between clinical outcome and the expression of proteins involved in active growth signaling pathways...
  4. doi request reprint Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 57:69-75. 2011
    ..However, it has been associated with a 5.8% incidence of secondary leukemias. A modified P6 (mP6) protocol with reduced exposure to chemotherapy is presented...
  5. pmc Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours
    J Mora
    Department of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Br J Cancer 91:1112-8. 2004
    ..The only well-characterised transcript among them was nuclear factor I-B3. Our results suggest a role for genes located telomeric of 9p21 in good risk NB...
  6. doi request reprint Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel
    Jaume Mora
    Department of Pediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    J Pediatr Hematol Oncol 31:723-9. 2009
    ..In this report we describe experience with gemcitabine-docetaxel in pediatric patients with relapsed or refractory sarcomas...
  7. ncbi request reprint Origin of neuroblastic tumors: clues for future therapeutics
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Passeig de Sant Joan de Deu num 2, 08950 Barcelona, Spain
    Expert Rev Mol Diagn 4:293-302. 2004
    ..In order to identify the cellular origin of these tumors, the embryology of the sympathetic nervous system is first reviewed and any archeological rests of normal development in the tumors are then discussed...
  8. doi request reprint Treatment of disseminated paraganglioma with gemcitabine and docetaxel
    Jaume Mora
    Department of Pediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 53:663-5. 2009
    ..More than 2 years after gemcitabine and docetaxel treatment, the patient remains symptom free. Gemcitabine and docetaxel could be a potential therapeutic strategy for this patient...
  9. pmc Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin
    Jaume Mora
    Department of Pediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Passeig de Sant Joan de Déu numero 2, 08950 Barcelona, Spain
    Neuro Oncol 9:39-46. 2007
    ..Using this I/C regimen for childhood intramedullary astrocytoma, we obtained remarkable clinicoradiological responses while avoiding the use of radiotherapy...
  10. ncbi request reprint Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center
    Jaume Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 98:1283-91. 2003
    ..In the current study, the authors present what to their knowledge is the longest follow-up presented to date (median, 20 years for survivors) of the largest group of DLBL patients treated with a single protocol at a single institution...
  11. ncbi request reprint Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma
    Jaume Mora
    Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Passeig de Sant Joan de Deu num 2, Barcelona 08950, Spain
    Cancer Lett 197:119-24. 2003
    ..Distinct gene expression patterns between metastatic and non-metastatic NB tumors have been identified. Validation of these results and further mechanistic studies may shed new light on the biology of metastasis in human NB...
  12. ncbi request reprint Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma
    Jaume Mora
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 94:2756-65. 2002
    ....
  13. ncbi request reprint Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma
    Jaume Mora
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 62:1761-7. 2002
    ..Spontaneously remitting or quiescent tumors were intact at all of the regions described above...
  14. pmc Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
    Sandra Acosta
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain
    BMC Dev Biol 9:12. 2009
    ..Histologically, NBT are composed by neuroblasts and Schwannian cells. In culture, neuroblastic (N-), substrate-adherent (S-) and intermediate phenotype (I-) cell subtypes arise spontaneously...
  15. doi request reprint Identification of tumoral glial precursor cells in neuroblastoma
    Sandra Acosta
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Fundació Sant Joan de Déu, Barcelona, Spain
    Cancer Lett 312:73-81. 2011
    ..During in vitro retinoic acid induced differentiation of NB cell lines, rare GD2(+)/S100A6 neuroblatic cells appeared. We conclude that GD2(+)/S100A6(+) neuroblasts may represent a tumoral glial precursor subpopulation in NBT...
  16. doi request reprint The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis
    Carla Casala
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu and Fundació Sant Joan de Déu, Barcelona, Spain
    Carcinogenesis 34:268-76. 2013
    ....
  17. doi request reprint A three-gene expression signature model for risk stratification of patients with neuroblastoma
    Idoia Garcia
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Edificio Docente 4th Floor, 08950 Esplugues de Llobregat, Barcelona 08950, Spain
    Clin Cancer Res 18:2012-23. 2012
    ..The purpose of this study was to develop a PCR-based predictor model to improve clinical risk assessment of patients with neuroblastoma...
  18. doi request reprint The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors
    Carmen de Torres
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain
    Cancer 115:2792-803. 2009
    ..The objective of the current study was to assess whether CaR and PTHrP participate in neuroblastoma differentiation pathways...
  19. pmc Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
    Cinzia Lavarino
    Developmental tumour biology laboratory, Hospital Sant Joan de Deu, Fundació Sant Joan de Déu, Barcelona, Spain
    BMC Cancer 9:44. 2009
    ..The aim of this study was to investigate chromosomal alterations and differential gene expression amongst infant disseminated NB subgroups...
  20. doi request reprint Use of angioembolization as an effective technique for the management of pediatric solid tumors
    Lucas Krauel
    Pediatric Surgery Department, Hospital Sant Joan de Deu, Universitat de Barcelona, Spain
    J Pediatr Surg 44:1848-55. 2009
    ..Nevertheless, the overall experience with angioembolization for the treatment of tumors is limited. We report our experience in 7 nonvascular solid pediatric tumors...
  21. ncbi request reprint Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma
    Miguel Alaminos
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Res 63:4538-46. 2003
    ....
  22. pmc Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma
    Laia Masvidal
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu and Fundació Sant Joan de Déu, Barcelona, Spain
    PLoS ONE 8:e59762. 2013
    ....
  23. doi request reprint Fibrolamellar hepatocellular carcinoma in an infant and literature review
    Ofelia Cruz
    Department of Oncology, Hospital San Joan de Deu, Universidad de Barcelona, Spain
    J Pediatr Hematol Oncol 30:968-71. 2008
    ..Induction chemotherapy using cisplatin and Adriamycin resulted in a partial response, however, refractory disease developed and regional metastasis precluded surgical resection. The child died from tumoral progression...
  24. pmc DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis
    Gemma Mayol
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Fundación Sant Joan de Déu, Barcelona, Spain
    PLoS ONE 7:e48401. 2012
    ..The results derived from this study provide new candidate epigenetic biomarkers associated with NB as well as insights into the molecular pathogenesis of this tumor, which involves a marked gene-specific hypomethylation...
  25. pmc Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
    Idoia Garcia
    Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Fundación Sant Joan de Déu, Barcelona, Spain
    Mol Cancer 9:277. 2010
    ..CHD5 gene and protein expression was reexamined after induction chemotherapy in a subset of high risk tumors to identify potential changes reflecting tumor response...
  26. doi request reprint Removal of the internal mammary sentinel node in breast cancer
    Anna Domènech-Vilardell
    Department of Nuclear Medicine, University Hospital of Bellvitge IDIBELL, Barcelona, Spain
    Nucl Med Commun 30:962-70. 2009
    ....
  27. doi request reprint Primary Ewing sarcoma of the tentorium presenting with intracranial hemorrhage in a child
    Ramon Navarro
    Department of Neurosurgery, Hospital Sant Joan de Deu, Barcelona, Spain
    J Neurosurg 107:411-5. 2007
    ..Additionally, the prognosis for intracranial ESFT might be better than the one for nonpineal central PNETs...
  28. ncbi request reprint Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas
    Wendy T Su
    Department of Surgery, Division of Pediatric Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Genet Cytogenet 154:131-7. 2004
    ..The expressed genes mapped closely to the complex amplicon reported in sarcomas, and they identify critical genes and pathways affected by 12q gene amplification...
  29. ncbi request reprint Epithelioid sarcoma with SYT-SSX1 fusion gene expression: molecular and cytogenetic analysis
    Carmen de Torres
    Laboratori de biologia molecular dels tumors del desenvolupament, Hospital Sant Joan de Deu, Barcelona, Passeig Sant Joan de Déu núm 2, 08950 Esplugues del Llobregat, Barcelona, Spain
    Cancer Genet Cytogenet 162:50-6. 2005
    ..The SYT-SSX1 gene fusion was identified in a small proportion of tumoral cells. This finding supports a likely common histogenetic background for both epithelioid sarcoma and synovial sarcoma...
  30. ncbi request reprint Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease
    J Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 91:435-42. 2001
    ..Although these patients generally have an excellent survival with minimal therapy, some do experience recurrence with lethal consequences...
  31. ncbi request reprint [The role of surgery for lung nodules in pediatric oncology]
    A Albert
    Servicio de Cirugia Pediatrica, Agrupació Sanitària Hospital Sant Joan de Déu Clínic, Universitat de Barcelona
    Cir Pediatr 19:228-31. 2006
    ..To evaluate the role of lung nodule surgery in pediatric cancer patients...
  32. doi request reprint Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma
    Núria Conde
    Department of Paediatric Oncology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 57:1071-3. 2011
    ..ASPS is a highly vascularized tumor and antiangiogenic therapy may have a role. We describe the use of the antiangiogenic combination bevacizumab and celecoxib in the preoperative management of a patient with an ASPS of the tongue...
  33. doi request reprint Brain stem tumors in children and adolescents: single institutional experience
    Magda Garzón
    Department of Pediatric Neurosurgery, Hospital Sant Joan de Deu, University of Barcelona, Passeig St Joan de Déu, 2, Esplugues de Llobregat, 08950 Barcelona, Spain
    Childs Nerv Syst 29:1321-31. 2013
    ..Pediatric brain stem tumors (BsT) are a heterogeneous group of diseases. Our aim was to analyze our experience to find out prognostic factors...
  34. pmc EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1
    Miguel Sáinz-Jaspeado
    Sarcoma Research Group, Laboratori d Oncologia Molecular, Institut d Investigació Biomèdica de Bellvitge IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain
    PLoS ONE 8:e71449. 2013
    ....
  35. pmc A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
    Ryan S Lee
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Invest 122:2983-8. 2012
    ..Our results demonstrate that high mutation rates are dispensable for the genesis of cancers driven by mutation of a chromatin remodeling complex. Consequently, cancer can be a remarkably genetically simple disease...
  36. doi request reprint Axenfeld-Rieger ocular anomaly and retinoblastoma caused by constitutional chromosome 13q deletion
    Ana Roche
    Department of Child Neurology, Hospital Sant Joan de Deu, Barcelona, Spain
    Pediatr Blood Cancer 54:480-2. 2010
    ..This is the first report of an association of AR, 13q deletion, and retinoblastoma, to be disclosed in patients born with such ocular and dysmorphic features...
  37. pmc Genetic heterogeneity and clonal evolution in neuroblastoma
    J Mora
    Departments of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Br J Cancer 85:182-9. 2001
    ..These findings suggest that NB exhibits a high degree of clonal heterogeneity and clonal evolution occurs during the course of therapy and clinical progression...
  38. ncbi request reprint N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
    N K Cheung
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Pediatr Oncol 36:227-30. 2001
    ....
  39. doi request reprint Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
    Jack F Shern
    1Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, NIH 2Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 3Broad Institute of MIT and Harvard, Cambridge 4Medical Oncology and Center for Cancer Genome Discovery, Dana Farber Cancer Institute 5Department of Pathology, Harvard Medical School, Boston, Massachusetts 6University of Nebraska Medical Center, Omaha, Nebraska 7Department of Pediatrics, Division of Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, Texas and 8Department of Pediatrics, Seattle Children s Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 9The Tumour Bank, The Children s Cancer Research Unit, The Children s Hospital at Westmead, Westmead, New South Wales, Australia 10Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain
    Cancer Discov 4:216-31. 2014
    ..In addition, a majority of rhabdomyosarcoma tumors alter the receptor tyrosine kinase/RAS/PIK3CA axis, providing an opportunity for genomics-guided intervention...
  40. doi request reprint ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-ioflupane SPET
    Paloma Fernández-Corcuera
    Aguts Unit, Benito Menni Hospital, c Antoni Pujades s n Sant Boi de Llobregat, 08830, Barcelona, Spain
    J Neural Transm 118:647-50. 2011
    ..After treatment, 123I-Ioflupane uptake was mildly increased in the left caudate nucleus, but uptake in right caudate nucleus was lower than in a pretreatment scan...
  41. ncbi request reprint Epstein-Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors
    Teresa M Cardesa-Salzmann
    Department of Pediatrics, Unitat Integrada Hospital Sant Joan de Déu Hospital Clínic University of Barcelona, Barcelona, Spain
    Pediatr Blood Cancer 47:964-7. 2006
    ..We present the case of a 20-month-old child with OMA associated with a microbiologically documented acute EBV infection and an occult thoracic ganglioneuroblastoma diagnosed 5 months later...
  42. doi request reprint Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease
    Maria Aiguabella
    Neurology Department, Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
    Epileptic Disord 12:239-42. 2010
    ..The final diagnosis was CJD. Continuous video-EEG monitoring revealed the ictal pattern of nonconvulsive SE to be periodic sharp wave complexes characteristic of CJD. [Published with video sequences]...
  43. ncbi request reprint Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell
    J Mora
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 61:6892-8. 2001
    ....
  44. ncbi request reprint Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience
    J Mora
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Oncologist 6:263-8. 2001
    ....
  45. ncbi request reprint Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma
    J Mora
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 7:1358-61. 2001
    ..In multivariant analysis, 19q13 LOH was associated with overall survival in local-regional International Neuroblastoma Staging System stages 1, 2, and 3 patients and was specifically present in tumors at the site of recurrence...
  46. ncbi request reprint Comparison of normal and tumor cells by laser capture microdissection
    Jaume Mora
    Department of Hematology and Oncology, Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain
    Methods Enzymol 356:240-7. 2002
  47. ncbi request reprint EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma
    Miguel Alaminos
    Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre, Madrid, Spain
    Cancer Res 65:2565-71. 2005
    ..03) and death of disease (Kendall tau, P = 0.03; r = 0.19). Thus, EMP3 is a good candidate for being the long-sought tumor suppressor gene located at 19q13 in gliomas and neuroblastomas...
  48. ncbi request reprint High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
    Alejandra Bruna
    Medical Oncology Program, Vall d Hebron University Hospital Research Institute, 08035 Barcelona, Spain
    Cancer Cell 11:147-60. 2007
    ..The epigenetic regulation of the PDGF-B gene dictates whether TGFbeta acts as an oncogenic factor inducing PDGF-B and proliferation in human glioma...
  49. pmc Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation
    Constanze Uschkereit
    J Med Genet 44:393-6. 2007
    ..This case demonstrates the high risk for the development of Wilms tumours in patients with germ line truncation mutations...
  50. ncbi request reprint Primitive hematopoietic malignant neoplasm presenting as a CD43-positive, small round, blue-cell tumor in an infant
    Jaume Mora
    Pediatr Blood Cancer 45:865-6. 2005